Oligonucleotide Synthesis Market worth $1,712.1 Million by 2019 - New Research Report by MarketsandMakets
(PRWEB) November 16, 2014 -- The Report “Oligonucleotide Synthesis Market by Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi), Product & Services (Equipment, Reagent, Primer, Probe, Custom Oligos) & End-User (Research, Pharmaceutical & Biotechnology), - Global Forecast to 2019”.
Get Detail Info on Report @ http://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html
Early buyers will receive 10% customization on this report.
This Report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the oligonucleotide synthesis market along with the estimates and forecasts of the revenue and competitive analysis.
The global oligonucleotide synthesis market is expected to reach $1,712.1 million by 2019 from $1,070.7 million in 2014, growing at a CAGR of 9.8% from 2014 to 2019.
Do Speak to Analyst @ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=200829350
The global oligonucleotide synthesis market is categorized on the basis of products and services, applications, end users, and geography. The synthesized oligonucleotides segment is expected to register the highest growth rate in the oligonucleotide synthesis market during the forecast period, owing to an increasing number of applications for synthesized oligonucleotides in research, diagnostics and therapeutics; and a growing demand for custom oligos.
The oligonucleotide synthesis market is segmented into equipment, reagents, and synthesized oligonucleotides. The synthesized oligonucleotides segment shows lucrative growth potential and represents new revenue pockets. High growth in these markets can be attributed to the growth in custom oligos services and increasing demand for intermediate-scale synthesis products.
The report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
Ask for PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=200829350
Apart from the comprehensive geographic and product analysis, and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by players in the industry over the last three years. In addition, the company profiles comprise the key players in the oligonucleotide synthesis market and their product portfolios, developments, and strategies
Among all growth strategies being adopted by players in this field, agreements, collaborations, and partnerships, and acquisitions accounted for the largest share of the overall growth strategies mapped from 2011 to 2014. Some leading players adopting these strategies are BioAutomation Corporation (U.S.), Eurofins Genomics (Germany) and GE Life Sciences (U.S.). Expansions accounted for the second largest share of the overall growth strategies adopted by players in the market.
About MarketsandMarkets
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 full time analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Bench marking presented with high quality analytically info graphics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: [email protected]
Visit MarketsandMarkets Blog http://www.marketsandmarketsblog.com/market-reports/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
Mr. Rohan, MarketsandMarkets, http://www.marketsandmarkets.com/, +91 9881155004, [email protected]
Share this article